GXFC3 (Combivir 150 mg / 300 mg)
Generic Name: lamivudine/zidovudine
Pill with imprint GXFC3 is White, Elliptical / Oval and has been identified as Combivir 150 mg / 300 mg. It is supplied by GlaxoSmithKline.
Combivir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GXFC3
Combivir
- Generic Name:
- lamivudine/zidovudine
- Imprint:
- GXFC3
- Strength:
- 150 mg / 300 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0595
- Inactive Ingredients:
-
- silicon dioxide colloidal
- hypromelloses
- magnesium stearate
- microcrystalline cellulose
- polyethylene glycol
- polysorbate 80
- sodium starch glycolate type A potato
- titanium dioxide
Note: Inactive ingredients may vary.
More about Combivir (lamivudine / zidovudine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 3 Reviews
- Generic Availability
- Drug class: antiviral combinations
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
